Phase I Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects with Actinic Keratosis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s119, 2020. DOI: 10.25251/skin.4.supp.119. Disponível em: https://skin.dermsquared.com/skin/article/view/1092. Acesso em: 10 may. 2025.